参与抑郁症,抗抑郁药治疗和相关体重变化之间的联系的机制
Tomas Kukucka1, Nikola Ferencova2, Zuzana Visnovcova2
1Clinic of Psychiatry, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Hospital Martin, 03659 Martin, Slovakia.
International journal of molecular sciences
|April 27, 2024
概括
重度抑郁症会影响生活质量,抗抑郁药治疗导致的体重变化往往会导致戒断. 本综述探讨了连接抑郁症,其治疗和食欲调节的复杂机制.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 大型抑郁症 (MDD) 显著损害生活质量和社会功能.
- 抗抑郁药物治疗至关重要,但经常因相关的体重变化而复杂,导致治疗不坚持.
- 了解MDD,其治疗方法和体重调节之间的联系对于患者的治疗结果至关重要.
研究的目的:
- 对重度抑郁症和抗抑郁药物治疗之间关于体重调节的机制性联系进行审查.
- 综合当前对抑郁症及其药物治疗如何影响食欲和体重的理解.
主要方法:
- 关于研究抑郁症,抗抑郁药机制和食欲控制之间的相互作用的文献综述.
- 对涉及恒常性和享乐性食欲调节回路的拟议病态机制的分析.
- 对神经形态学和神经生理学变化的检查.
主要成果:
- 在MDD,抗抑郁作用和食欲/体重调节之间存在显著的机制重叠.
- 这涉及到恒常性 (幽默) 和享乐性 (多巴胺) 食欲回路的调节障碍.
- 抗抑郁药引起的体重变化是影响治疗坚持的一个公认问题.
结论:
- 抑郁症,抗抑郁药治疗和体重变化之间的关系是复杂的和多因素的.
- 需要进一步的研究来充分阐明这些机制,并制定减轻负面体重影响的策略.
- 解决体重变化对于改善长期治疗坚持和大抑郁症治疗效果至关重要.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
227
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
227
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
377
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
377
Antidepressant Drugs: Overview
459
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
459
Depression: Overview
242
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
242
Depressive Disorders: Etiology
71
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
71
G-protein Coupled Receptors
118.5K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
118.5K


